Robert1015

I have spent the last week speaking with different hospitals about neonatal exchange transfusions, specifically, whether removing excess anticoagulant is necessary or not. some of them, even when using CPDA, are removing the excess anticoagulant, and other places are reconstituting the product without the removal of the additional CPDA. What is everybody's thought on this? Should the excess anticoagulant (CPDA) be removed? Thanks, Robert

Does a transfusion service need to be registered with the FDA in order to set up recostituted whole blood for neonatal exchange transfusions? How do you go about training your staff and making sure they're competent in performing such a procedure? Thanks.

just a quick question: i've been getting different opinions on the kind of product used for neonatal exchange transfusions. some of the people i've spoken with, are using O neg whole blood for such procedures (leuko, irradiated, CMV neg, and Hgb S neg). Is this an acceptable product????